Search clinical trials for: Thromboembolic

Total 337 results

PharmaDiall Ltd.

Active, not recruiting

A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement

Venous Thromboembolism

Russian Federation
NHS Lothian
University of Edinburgh

Completed

Clotting Parameters After Medical Abortion (C-PLAN)

Venous Thromboembolism | Abortion, Second Trimester | Venous Thromboses | Abortion Early | Venous Thromboembolic Disease | Clotting Disorder | Abortion, Complete | Termination of Pregnancy Complicated by Embolism

United Kingdom
Andres muñoz
Hospital Clinic of Barcelona; LEO Pharma; Hospital General Universitario Elche; Hospital Universitario Ramon y Cajal and other collaborators

Completed

A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient (ONCOTHROMB)

Genetic Predisposition | Cancer-associated Thrombosis

Spain
Centre Antoine Lacassagne

Completed

Thromboembolic Risk Screening in Patients With Cancer and COVID-19 (NEOTHROCOVID)

Covid19 | Thromboembolism | Neoplasms Malignant

France, Monaco
University Hospital, Brest

Completed

New Genetic Mutations in Thromboembolic Venous Disease Idiopathic. Study "FIT GENETIQUE". (Fit-Génétique)

Thromboembolic Venous Disease

France
Thomas Staudinger

Terminated

PGE1 as Additive Anticoagulant in ECMO-Therapy (ECMO_PGE1)

Extracorporeal Membrane Oxygenation | Respiratory Distress Syndrome, Adult

Austria
Mesoblast, Inc.

Completed

Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)

Graft Versus Host Disease

United States, Australia, Canada
Bayer

Completed

Study to Assess the Safety, Tolerability, Effects on the Body, Absorption, Distribution and Elimination of 25 mg BAY2433334 in Renal Impairment Including Renal Replacement Therapy ("Dialysis")

Prevention of Thromboembolic Events

Germany
Centro Hospitalar Tondela-Viseu
Portuguese IBD Group

Completed

Inflammatory Bowel Disease and Thromboembolic Events

Inflammatory Bowel Diseases | Coagulation Disorder | Thromboembolism

Portugal
Pfizer

Withdrawn

A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Pulmonary Embolism | Cerebral Stroke | Thrombosis, Deep Vein
Ottawa Hospital Research Institute

Completed

Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS) (PREDICTORS)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Thromboembolic Disease Recurrent | Recurrent Thromboembolic Disease

Canada, Netherlands, Switzerland
Bayer

Completed

A Study Investigating Routine Practice of Chronic Thromboembolic Pulmonary Hypertension Management in EMEA Countries (EMEA CTEPH)

Hypertension, Pulmonary

Turkey, Russian Federation, Kazakhstan, Lebanon, Saudi Arabia, Kyrgyzstan
AHMET ZENGIN

Completed

The Role of Matrix Metalloproteinase 2 and 9 Enzymes in Developing Chronic Thromboembolic Pulmonary Hypertension

Chronic Thromboembolic Pulmonary Hypertension

Turkey
Sundara Reddy
Microdermis Corporation

Completed

ProvodineTM Decreases Hand Contamination

Hand Hygiene

United States
Les Laboratoires des Médicaments Stériles

Completed

Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® (ENOXACARE)

Gastrointestinal Neoplasms | Thromboembolic Event

Tunisia
Johns Hopkins University
Bristol-Myers Squibb

Completed

Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data

Kidney Failure, Chronic | Venous Thromboembolic Disease

United States
International CTEPH Association

Terminated

Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy (PEA Bridging Study)

Chronic Thromboembolic Pulmonary Hypertension | CTEPH

Germany, United States, United Kingdom, France
Actelion
EPS Corporation; Imepro Inc.; General Laboratory, BML, Inc.; Mitsubishi Logistics...

Terminated

A Clinical Study to Find Out if Macitentan is Effective and Safe in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).

Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Japan
Nantes University Hospital

Terminated

Prospective and Monocentric Study of the Incidence of Venous Thromboembolic Disease (VTE) in Spinal Cord Injury (SCI) Patient Between 3 and 12 Months After SCI (IMATEM)

Spinal Cord Injury

France
CSL Behring
Kaiser Permanente

Completed

An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

Hemorrhage

United States
Kartal Kosuyolu Yuksek Ihtisas Education and Research...

Completed

High PEEP Application Following Pulmonary Thromboendarterectomy; Does it Have Any Impact on Outcome?

Reperfusion Injury After Pulmonary Thromboendarterektomy

Turkey
Thrombosis Research Institute
Bayer

Completed

Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events (GARFIELD-VTE)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
Centre Hospitalier Universitaire de Saint Etienne

Completed

Predictors of Attempted Inferior Vena Cava Filters Retrieval.

Venous Thromboembolic Disease

France
Jeffrey Zwicker, MD
National Heart, Lung, and Blood Institute (NHLBI); Quercegen Pharmaceuticals

Completed

Cancer Associated Thrombosis and Isoquercetin (CATIQ) (CATIQ)

Thromboembolism of Vein VTE in Colorectal Cancer | Thromboembolism of Vein in Pancreatic Cancer | Thromboembolism of Vein in Non-small Cell Lung Cancer

United States
Leiden University

Completed

Early Non-invasive Detection of CTEPH After Pulmonary Embolism (InShape2)

Chronic Thromboembolic Pulmonary Hypertension

Belgium, Netherlands, Poland
Rigshospitalet, Denmark

Completed

Frequency of Vascular Events With Short-term Thromboprophylaxis in Fast-track Hip and Knee-arthroplasty. (FETA)

Thromboembolic Events | Post-operative Bleeding

Denmark
Assistance Publique - Hôpitaux de Paris
Bayer

Completed

Riociguat Versus Balloon Pulmonary Angioplasty in Non-operable Chronic thromboEmbolic Pulmonary Hypertension (RACE)

Chronic Thromboembolic Pulmonary Hypertension

France
Bayer
Janssen Research & Development, LLC

Completed

A Trial to Learn How a New Liquid Form of Rivaroxaban Behaves and How Safe it is Compared to the Current Tablet Form of Rivaroxaban in Healthy Male Participants

Thromboembolic Disorders

Germany
Fundación Pública Andaluza para la gestión de la...

Unknown

Study on the Effect of a Physical Training Structured Program After a Pulmonary Thromboembolism (TEP-RR)

Pulmonary Embolism

Spain
iPHNET (italian Pulmonary Hypertension NETwork)

Unknown

CTEPH in Patients With Prior Pulmonary Embolism and Risk Score Validation (CTEPH-SOLUTION)

Pulmonary Embolism | Chronic Thromboembolic Pulmonary Hypertension

Italy
Assistance Publique - Hôpitaux de Paris

Unknown

Evaluation of NETs in Patients With Solid Cancers Associated With a High Risk of Venous Thromboembolic Events (Flownet)

Gastric Cancer | Colorectal Cancer | Pancreatic Cancer

France
Second Affiliated Hospital of Wenzhou Medical University

Unknown

An Analysis Into the Cause and Preventional Method of Thromboembolic Disease in Gynecological Surgery

Thromboembolic Disease | Gynecological Surgery

China
Medical University of Warsaw
European Health Centre Otwock

Completed

Platelet Reactivity and Treatment With Prostacyclin Analogues in Pulmonary Arterial Hypertension (PAPAYA)

Pulmonary Hypertension

Poland
Novartis Pharmaceuticals

Withdrawn

Prevention of Thromboembolic Events in Total Knee Replacement Patients

Thrombotic Disorders
Novartis Pharmaceuticals

Withdrawn

Efficacy and Safety of MAA868 in Patients With Atrial Fibrillation

Atrial Fibrillation
Chiesa Alessandro Felice

Completed

Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19

SARS Virus

Switzerland
Nisantasi University

Completed

Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia (Covid-19)

Corona Virus Infection | Thromboembolic Disease

Turkey
Atrial Fibrillation Network

Completed

Prospective Registration and Assessment of Serious Adverse Events Within the AFNET (AFNET A7)

Atrial Fibrillation | Assessment of Serious Advers Events | Thromboembolic and Bleeding Complications | Complications of Antiarrhythmic Drugs or Invasive Procedures | Assessment by a Critical Event Committee

Germany
University Hospital, Brest

Completed

Venous Disease Thromboembolic and Amyotrophic Lateral Sclerosis (TESLA)

Lateral Amyotrophic Sclerosis | Venous Thrombo-embolic Desease

France
Centre Hospitalier Universitaire de Saint Etienne
CHU Saint-Etienne - Laboratoire de Pharmacologie - Toxicologie - Gaz du sang

Withdrawn

Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention (COV-ENOX)

Sars-CoV2

France
Assistance Publique - Hôpitaux de Paris
Bristol-Myers Squibb; Daiichi Sankyo, Inc.

Terminated

Oral Anticoagulant Peri-procedural Management in Patients Undergoing an Oral Surgery, Implantology or Periodontology (PRADICO)

Invasive Procedure | Oral Anticoagulants

France
King's College Hospital NHS Trust
Bayer

Completed

Follow-up in Rivaroxaban Patients in Setting of Thromboembolism (FIRST)

Venous Thromboembolism

United Kingdom
Karolinska Institutet

Completed

Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients

Covid-19 | Bleeding | Thromboembolic Events

Sweden
Thomas Guerrero

Completed

Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events

Pulmonary Embolism | Pulmonary Thromboembolisms

United States
University of California, Los Angeles

Completed

Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry (RAPID)

Pulmonary Embolism | Deep Venous Thrombosis | Venous Thromboembolic Disease | Right Heart Pathology
Actelion

Completed

Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (MERIT-1)

Chronic Thromboembolic Pulmonary Hypertension

United Kingdom, Belgium, Ukraine, Germany, Switzerland, Hungary, China, Korea, Republic of, Mexico, Czechia, France, Lithuania, Poland, Russian Federation, Thailand, Turkey
University Hospital, Strasbourg, France

Unknown

Thromboembolic Events in Severe COVID-19 Patients (COVICLOT)

Pulmonary Thromboembolism

France
Sociedad Espanola de Angiologia y Cirugia Vascular

Unknown

Influence of COVID-19 Infection in Thromboembolic Venous Disease: National Cohort Study (TVP-COVID-RIV)

COVID-19

Spain
National Taiwan University Hospital

Unknown

Taiwan Cohort - Chronic ThromboEmbolic Pulmonary Hypertension Registry

The Geodemographics of CTEPH in Taiwan

Taiwan
Medicalps
Icadom; AG2R La Mondiale; AVALUN; ORIADE NOVIALE; SIL-LAB INNOVATIONS; TASDA

Completed

INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA) (INRADOM)

Vitamine K Antagonist (VKA) Treatment | International Normalized Ratio (INR) Measure at Home | Thromboembolic Pathology

France

Search clinical trials for: Thromboembolic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations